Jun 30 2011
System requirements for all workbenches from CLC bio
Jun 07 2011
Wouldn’t it be cool if someone put in the effort to write a huge knowledge bank on all kinds of aspects that relates to Next Generation Sequencing? Well, it turns out that someone already did - and it’s free!
This goldmine of sequencing insights has been created by the team of experts at BlueSEQ – maybe you have heard of them and their sequencing exchange already? Anyway, their knowledge bank gives you a detailed comparison of the different sequencing platforms, including the pros and cons of each of them – check it out here
Furthermore you can get unbiased recommendations of which platforms are ideal for which types of applications, like they suggest using 454 for de novo projects of prokaryote genomes, or either Illumina or LifeTech’s SOLiD for transcriptome sequencing - and the list goes on and on.
A lot of this information can of course be found around the internet on vendor websites and forums like SeqAnswers. But the nice thing about this knowledge bank is that you don’t have to trawl through endless pages to find the exact bit of information you need. It’s all there and curated by sequencong pros who don’t have a bias towards any of the platforms.
This impressive resource, including their glossary, can be extremely helpful to scientists who’re new to sequencing or researchers who don’t spend their whole working life doing sequencing, but maybe rather run a couple of projects a year, and then spend the majority of their time analyzing the sequencing data.
So what’s missing? As both platforms mature, I look forward to reading more about how BlueSEQ’s experts see Ion Torrent and PacBio fits in to the comparison table of all the major sequencing platforms and what applications are ideal to run on which platforms - perhaps also taking economics into question!?
May 19 2011
Here you can see our interview with Dr. Martin Coetzee, Researcher at Forestry and Agricultural Biotechnology Institute (FABI) and Dr. Arshad Ismail, GS Technology Platform Manager at Inqaba Biotec.
May 10 2011
As part of the local government’s initiative to identify, support, and promote successful start-up companies in and around the city of Aarhus, the Mayor, Nicolai Wammen, stopped by our offices last week and met with the founding brothers of CLC bio.
CEO at CLC bio, Thomas Knudsen - Mayor of Aarhus, Nicolai Wammen - CSO at CLC bio, Bjarne Knudsen
The meeting was very positive and the Mayor found the story and the strategies behind building CLC bio since 2005, very intriguing.
In coordination with CLC bio being recognized as a successful local startup in Aarhus - and now turned into a profitable global company with a massive growth and 98% export - our CEO, Thomas Knudsen, will present our story as a source of inspiration for all the new entrepreneurs, when the most promising new local startups are rewarded at the municipal hall on May 25th.
Apr 07 2011
Not all our customers are aware of our CLC Developer Kit - a free and open API to customize and create your own features and algorithms that plug right in to our line of workbenches or on our server. However, there is a lot of programmers, bioinformaticians, and biologists with coding expertise that use our API to create their own plugins. And just recently we passed an impressive number of 1000 registered developers on our developer forum: http://www.clcdeveloper.com
We wanted to celebrate that, so we contacted the 1000th developer who registered - Raimundas Ražanskas, PhD, from the Institute of Biotechnology at the Vilnius University in Lithuania - and invited him for a trip to our headquarters in Denmark, all expenses paid! In Aarhus, he got to meet our Director of Enterprise Solutions & Worldwide Developer Relations, Mikael Flensborg, who is the chief architect behind our API.
Raimundas Ražanskas states:
First of all, I’m not a bioinformatician but a molecular biologist - but I do some small software and scripts now and then, and plan to do more coding and data analysis in the future, as the Vilnius University is planning to acquire a next generation sequencer. My idea is to add some specific features to CLC bio’s workbench, which is why I registered on clcdeveloper.com
Mikael Flensborg, continues:
I have visited a lot of institutions everywhere in the world and done workshops on our API, and it’s really positive to see the interest for developing customized plugins. As a company we know we can’t cover every feature and algorithm that all the scientists in the world want to do, so in that respect we really want to encourage researchers to do this on their own - and with some coding experience it’s relatively straightforward. For commercial software companies, using our API is also an excellent opportunity to reach a wide audience of CLC bio software installations - like for example Omixon have done.
Raimundas Ražanskas rounds off by stating:
Visting CLC bio is a very good experience and the company has many young and motivated specialists, and obviously they make very good software. I like it here in Aarhus!
